The Center for Continuing Medical Education (CCME)
  1. Home
  2. Grand Rounds
  3. Immunology, Infection, and Immuno-oncology (i3) Seminar Series
  4. "How External Signals and Gene Regulatory Networks Integrate to Control Differentiation During B cell Immune Responses" Mark Jay Shlomchik, MD, PhD, UPMC Endowed and Distinguished Professor, Department of Immunology, University of Pittsburgh

"How External Signals and Gene Regulatory Networks Integrate to Control Differentiation During B cell Immune Responses" Mark Jay Shlomchik, MD, PhD, UPMC Endowed and Distinguished Professor, Department of Immunology, University of Pittsburgh

Immunology, Infection, and Immuno-oncology (i3) Seminar Series

Tuesday, September 17, 2024 at 12:00 PM

This grand round has already taken place.

170 DHLRI (Simulcast EAIC130, NCH Viewing room RB2.5.1) - Columbus, OH
September 17th, 2024
1.00 AMA PRA Category 1 Credit™ Hours

Description

New discoveries in the fields of immunology, infection, and Immunotherapeutics are being made that range from basic research to best practices in clinical care. To make well-informed decisions on current and future care practices, physicians need to maintain familiarity with the latest discoveries to keep up with these advancements to effectively treat and diagnose patients.

Dates and Times

Start: 9/17/2024 12:00 PM
End: 9/17/2024 1:00 PM

Objectives

1. Demonstrate familiarity with the latest discoveries in the pathophysiology of infections, immune disorders and relevant cancers immunology and immunotherapeutics
2. Deliver the knowledge gained to enhance their clinical skill and practice
3. Interpret the latest research in immunology and immunotherapeutics and apply it to everyday practice methods.

Speakers

  • Mark Shlomchik, MD
    • "How External Signals and Gene Regulatory Networks Integrate to Control Differentiation During B cell Immune Responses"

Location

170 DHLRI (Simulcast EAIC130, NCH Viewing room RB2.5.1)
473 W. 12th Ave.
EAIC130, 254 Energy Advancement and Innovation Center
Columbus, OH 43210

Accreditation Statement

The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

AMA Credit Designation Statement

The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure

Among all the planners, speakers, and reviewers for this educational activity only Dr. Mark Shlomchik, has a relevant financial relationship with a commercial interest (defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients), that relates to the content that will be discussed in this educational activity. All other speakers, faculty, planners, the reviewer and the CME provider have no relevant financial relationships to disclose.

Speaker Company Relationship
Dr. Mark Shlomchik
BlueSphere Bio Stockholder, Member BOD, CSO
Bain Capital Consultant
Merida Biosciences Stockholder, Consultant
Third Rock Ventures Consultant
SouffleTx Consultant
Flagship Pioneering Medicines Consultant
Vida Ventures Consultant
Capstan Bio Consultant
Dren Bio Consultant
ReNAgade Consultant
Anaptys Bio Consultant

Need help with this Grand Round Session?

Please contact the Grand Round coordinator listed below:

Bonnie Cooper
Email: bonnie.cooper@osumc.edu